A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This is a multicenter study to evaluate the efficacy and safety of 2 different doses of
DR-3001. For eligible subjects the duration of the study will be approximately 20 weeks; this
will consist of a 4-week screening period, a 12-week treatment period and a 4-week follow-up
period. Subjects will have physical and laboratory exams, including blood draws at each
scheduled visit. Subjects will be required to insert a vaginal ring (replacing it every 4
weeks) and to keep a daily record of their toilet voids (including time,type and volume) for
3 days at several specified time points.